About Pearsanta
Pearsanta is a Healthcare company based in Richmond (United States) founded in 2023. It offers personalized medical diagnostics and monitoring through data-driven technology. It operates on a B2B and D2C model. Pearsanta has completed 1 acquisition, including MDNA Life Sciences. Pearsanta offers products and services including AditxtScore and Diagnostic Solutions. Its focus areas include Biotech, Innovation Tech, Diagnostic Tools and Infectious Disease Testing. Its legal entity is Pearsanta, Inc. Its competitors include Curative, Proof Diagnostics and Aptitude Medical; 1 of its 3 listed competitors has raised funding.
Company details
Pearsanta is a medical diagnostic company that develops personalized, data-driven solutions for healthcare, focusing on biosample collection, processing, and actionable insights based on patient demographics, genetics, and risk factors. It uses patented technology and a CLIA-certified monitoring center to deliver innovations like diagnostic tools for conditions such as COVID-19. Operating in the US, Pearsanta targets providers and patients to disrupt traditional healthcare with precise monitoring and insights, aiming for optimal health outcomes through diverse delivery channels.
- Headquarters Richmond, United States
- SectorsHealthcare
- Phone•••• ••••
- Website pearsanta.com
- Legal Name Pearsanta, Inc.
- Investments & Acquisitions
Products & Services of Pearsanta
Pearsanta offers a comprehensive portfolio of products and services, including AditxtScore and Diagnostic Solutions.
Diagnostic application for COVID-19 using personalized data insights.
Tools for biosample processing and actionable health monitoring services.
People of Pearsanta
1 people are tracked at Pearsanta (1 in team).
| Name | Role | Group |
|---|---|---|
Amy Bredehoft | Senior Quality Specialist | Team |
Complete people profiles for Pearsanta
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pearsanta
Pearsanta has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MDNA Life Sciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Genomic and molecular diagnostics based on mitochondrial genome are provided. | mdnalifesciences.com | Jupiter, United States | 2001 | Jan 2024 | $25M |
Complete acquisition details for Pearsanta
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Pearsanta
2 dated milestones of Pearsanta across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Pearsanta is founded.
- Acquisition Acquires MDNA Life Sciences.
Competitors of Pearsanta
Pearsanta has 3 listed competitors in our database, 1 of them funded. They include Curative, Proof Diagnostics and Aptitude Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| curative.com | 2020 | Austin, United States | $9.8M | 2,251 | Curative is recognized for providing affordable employer-sponsored health insurance. | |
| proofdx.com | 2020 | Cambridge, United States | CRISPR-based COVID-19 molecular testing devices are manufactured. | |||
| aptitudemedical.com | 2011 | Goleta, United States | 44 | Provider of at-home COVID and COVID/Flu tests |
Detailed competitors of Pearsanta
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Pearsanta (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pearsanta
Complete news archive for Pearsanta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pearsanta
Pearsanta was founded in 2023.
Pearsanta is headquartered in Richmond, United States. It is registered at Richmond, Virginia, United States.
Pearsanta is a medical diagnostic company that develops personalized, data-driven solutions for healthcare, focusing on biosample collection, processing, and actionable insights based on patient demographics, genetics, and risk factors. It uses patented technology and a CLIA-certified monitoring center to deliver innovations like diagnostic tools for conditions such as COVID-19. Operating in the US, Pearsanta targets providers and patients to disrupt traditional healthcare with precise monitoring and insights, aiming for optimal health outcomes through diverse delivery channels.
Pearsanta's top competitors include Curative, Aptitude Medical and Proof Diagnostics.
Pearsanta offers AditxtScore and Diagnostic Solutions.
Pearsanta has made 1 acquisition, including MDNA Life Sciences.
Pearsanta operates through Pearsanta, Inc..